Switch theme
Sign up to access all valuation multiples
MedTech Solutions SA formerly E-shopping Group SA main activity is based on conducting business through its own e-shops that operate in the dropshipping sales model.
2014
10
LTM Revenue n/a
LTM EBITDA n/a
$1.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
MedTech Solutions has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, MedTech Solutions achieved revenue of $0.5M and an EBITDA of -$0.2M.
MedTech Solutions expects next 12-month revenue of XXX and NTM EBITDA of XXX
See MedTech Solutions valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $0.4M | $0.5M | XXX | XXX | XXX |
| Gross Profit | $14K | $0.1M | XXX | XXX | XXX |
| Gross Margin | 3% | 21% | XXX | XXX | XXX |
| EBITDA | -$0.2M | -$0.2M | XXX | XXX | XXX |
| EBITDA Margin | -47% | -38% | XXX | XXX | XXX |
| Net Profit | -$0.1M | -$0.2M | XXX | XXX | XXX |
| Net Margin | -14% | -39% | XXX | XXX | XXX |
| Net Debt | $0.1M | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 29, 2025, MedTech Solutions's stock price is PLN 0 (or $0).
MedTech Solutions has current market cap of PLN 3.8M (or $1.0M), and EV of PLN 3.9M (or $1.0M).
See MedTech Solutions trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.0M | $1.0M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 29, 2025, MedTech Solutions has market cap of $1.0M and EV of $1.0M.
MedTech Solutions's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate MedTech Solutions's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for MedTech Solutions and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.0M | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | -5.0x | XXX | XXX | XXX |
| P/E | -4.7x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -3.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMedTech Solutions's NTM/LTM revenue growth is n/a
MedTech Solutions's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged n/a for the same period.
Over next 12 months, MedTech Solutions's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate MedTech Solutions's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for MedTech Solutions and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 26% | XXX | XXX | XXX | XXX |
| EBITDA Margin | N/A | XXX | XXX | XXX | XXX |
| EBITDA Growth | 2% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | N/A | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 1% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Brillia Inc | XXX | XXX | XXX | XXX | XXX | XXX |
| Adore Beauty | XXX | XXX | XXX | XXX | XXX | XXX |
| Temple & Webster | XXX | XXX | XXX | XXX | XXX | XXX |
| BIKE24 | XXX | XXX | XXX | XXX | XXX | XXX |
| ABOUT YOU | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MedTech Solutions acquired XXX companies to date.
Last acquisition by MedTech Solutions was XXXXXXXX, XXXXX XXXXX XXXXXX . MedTech Solutions acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was MedTech Solutions founded? | MedTech Solutions was founded in 2014. |
| Where is MedTech Solutions headquartered? | MedTech Solutions is headquartered in Poland. |
| How many employees does MedTech Solutions have? | As of today, MedTech Solutions has 10 employees. |
| Is MedTech Solutions publicy listed? | Yes, MedTech Solutions is a public company listed on WAR. |
| What is the stock symbol of MedTech Solutions? | MedTech Solutions trades under MDT ticker. |
| When did MedTech Solutions go public? | MedTech Solutions went public in 2017. |
| Who are competitors of MedTech Solutions? | Similar companies to MedTech Solutions include e.g. Brillia Inc, Adore Beauty, Temple & Webster, BIKE24. |
| What is the current market cap of MedTech Solutions? | MedTech Solutions's current market cap is $1.0M |
| What is the current revenue growth of MedTech Solutions? | MedTech Solutions revenue growth between 2023 and 2024 was 26%. |
| Is MedTech Solutions profitable? | Yes, MedTech Solutions is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
